ESSILORLUXOTTICA 1/2/O.N. - Asset Resilience Ratio
ESSILORLUXOTTICA 1/2/O.N. (ESLC) has an Asset Resilience Ratio of 0.60% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does ESSILORLUXOTTICA 1/2/O.N. carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2023)
This chart shows how ESSILORLUXOTTICA 1/2/O.N.'s Asset Resilience Ratio has changed over time. See ESLC total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down ESSILORLUXOTTICA 1/2/O.N.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ESSILORLUXOTTICA 1/2/O.N. (ESLC) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €373.00 Million | 0.6% |
| Total Liquid Assets | €373.00 Million | 0.60% |
Asset Resilience Insights
- Limited Liquidity: ESSILORLUXOTTICA 1/2/O.N. maintains only 0.60% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ESSILORLUXOTTICA 1/2/O.N. Industry Peers by Asset Resilience Ratio
Compare ESSILORLUXOTTICA 1/2/O.N.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for ESSILORLUXOTTICA 1/2/O.N. (2023–2023)
The table below shows the annual Asset Resilience Ratio data for ESSILORLUXOTTICA 1/2/O.N..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | €1.00 Million ≈ $1.17 Million |
€60.52 Billion ≈ $70.76 Billion |
-- |
About ESSILORLUXOTTICA 1/2/O.N.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Ni… Read more